While these data shed light on host factors that may increase the likelihood of developing CRC after colibactin exposure, future studies are needed to determine the mechanism by which PSMD4 sensitizes cells to colibactin and if this response is specific to the toxin or a more ubiquitous response to DNA alkylating agents or genotoxins. The gene discussed is PSMD4; the disease is colorectal carcinoma.